Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Lymphoma
Interventions: DIAGNOSTIC_TEST: Contrast Microhalography (CEM)
Sponsor: Harvard School of Public Health (HSPH)
Collaborators: National Cancer Institute (NCI)|Botswana Harvard AIDS Institute Partnership|Massachusetts General Hospital|Brigham and Women's Hospital